Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Metadata
Title
Lamifiban
A Viewpoint by Robert A. Harrington
Author
Robert A. Harrington
Publication date
01-02-1999
Publisher
Springer International Publishing
Published in
Drugs / Issue 2/1999
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-199957020-00010

Other articles of this Issue 2/1999

Drugs 2/1999 Go to the issue

Adis New Drug Profile

Sibrafiban

Review Article

Clinical and Preclinical Modulation of Chemotherapy-Induced Toxicity in Patients with Cancer

Adis New Drug Profile

Basiliximab

Disease Management

Preventing Postoperative Infections

Adis New Drug Profile

Basiliximab

Disease Management

Current Pharmacological Approaches to the Therapy of Varicella Zoster Virus Infections